These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6085768)

  • 1. Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline.
    Preston KL; Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 55():151-7. PubMed ID: 6085768
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
    Preston KL; Bigelow GE; Bickel W; Liebson IA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):985-93. PubMed ID: 1376362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure.
    Oliveto A; Poling J; Kosten TR; Gonsai K
    Eur J Pharmacol; 2004 May; 491(2-3):157-68. PubMed ID: 15140632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure.
    Oliveto AH; Rosen MI; Kosten TA; Hameedi FA; Woods SW; Kosten TR
    Exp Clin Psychopharmacol; 1998 May; 6(2):169-78. PubMed ID: 9608349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-way drug discrimination in post-addict volunteers: hydromorphone, pentazocine, and saline.
    Bickel WK; Preston KL; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1986; 67():177-83. PubMed ID: 2427951
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental analysis of conditioning factors in human narcotic addiction.
    O'Brien CP
    Pharmacol Rev; 1975 Dec; 27(4):533-43. PubMed ID: 1223916
    [No Abstract]   [Full Text] [Related]  

  • 12. Human d-amphetamine drug discrimination: testing with d-amphetamine and hydromorphone.
    Lamb RJ; Henningfield JE
    NIDA Res Monogr; 1989; 95():423-4. PubMed ID: 2484268
    [No Abstract]   [Full Text] [Related]  

  • 13. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons.
    Valentino RJ; Herling S; Woods JH
    J Pharmacol Exp Ther; 1983 Feb; 224(2):307-13. PubMed ID: 6681632
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
    Strain EC; Walsh SL; Bigelow GE
    Psychopharmacology (Berl); 2002 Jan; 159(2):161-6. PubMed ID: 11862344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1983 Apr; 43():238-44. PubMed ID: 6192340
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of buprenorphine in methadone-dependent volunteers.
    Strain EC; Bigelow GE; Preston KL; Liebson I
    NIDA Res Monogr; 1990; 105():584. PubMed ID: 1715035
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-Amphetamine discrimination established under a conditional discrimination procedure in pigeons.
    Watanabe S
    Yakubutsu Seishin Kodo; 1983 May; 3(1):45-50. PubMed ID: 6666378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of drug addicts with methadone: guidelines for Zurich and evaluation of results].
    Uchtenhagen A
    Schweiz Rundsch Med Prax; 1988 Mar; 77(13):351-3. PubMed ID: 3375658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.